Evidence map›Paper›PMID 40370304›Full record

ArticleJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2025

Neuronal deterioration associated with hyperexcitability under mild chronic cerebral hypoperfusion.

Takuya Urushihata, Manami Takahashi, Masafumi Shimojo, Yuhei Takado, Nobuhiro Nitta, Yosuke Tajima, Kazuto Masamoto, Iwao Kanno, Yutaka Tomita, Naruhiko Sahara and 7 more

Abstract read
In one paragraph

Article in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Takuya UrushihataDepartment of Functional Brain Imaging, Institute for Quantum Medical Science, QST, Chiba, Japan.
Manami TakahashiDepartment of Functional Brain Imaging, Institute for Quantum Medical Science, QST, Chiba, Japan.
Masafumi ShimojoDepartment of Functional Brain Imaging, Institute for Quantum Medical Science, QST, Chiba, Japan.
Yuhei TakadoDepartment of Functional Brain Imaging, Institute for Quantum Medical Science, QST, Chiba, Japan.
Nobuhiro NittaApplied MRI Research, Department of Molecular Imaging and Theranostics, Institute for Quantum Medical Science, QST, Chiba, Japan.
Yosuke TajimaDepartment of Functional Brain Imaging, Institute for Quantum Medical Science, QST, Chiba, Japan.
Kazuto MasamotoDepartment of Functional Brain Imaging, Institute for Quantum Medical Science, QST, Chiba, Japan.ORCID 0000-0002-2958-9627
Iwao KannoDepartment of Functional Brain Imaging, Institute for Quantum Medical Science, QST, Chiba, Japan.ORCID 0000-0002-1844-406X
Yutaka TomitaDepartment of Neurology, Keio University School of Medicine, Tokyo, Japan.
Naruhiko SaharaDepartment of Functional Brain Imaging, Institute for Quantum Medical Science, QST, Chiba, Japan.
Masaya TakahashiDepartment of Radiology, Juntendo University School of Medicine, Tokyo, Japan.
Takayuki ObataApplied MRI Research, Department of Molecular Imaging and Theranostics, Institute for Quantum Medical Science, QST, Chiba, Japan.ORCID 0000-0001-7678-5033
Hiroshi ItoDepartment of Functional Brain Imaging, Institute for Quantum Medical Science, QST, Chiba, Japan.
Tetsuro YamashitaDepartment of Biological Chemistry, Faculty of Agriculture, Iwate University, Morioka, Japan.
Tetsuya SuharaDepartment of Functional Brain Imaging, Institute for Quantum Medical Science, QST, Chiba, Japan.
Makoto HiguchiDepartment of Functional Brain Imaging, Institute for Quantum Medical Science, QST, Chiba, Japan.
Hiroyuki TakuwaDepartment of Functional Brain Imaging, Institute for Quantum Medical Science, QST, Chiba, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic cerebral hypoperfusion (CCH) has been indicated to impair cognitive and diverse brain functions. However, the neural mechanisms linking these cerebrovascular and phenotypic alterations remain unclear. Here, we investigated the effect of CCH on neuronal activity in male mice with unilateral common carotid artery occlusion using optical imaging and MRI. Our examinations revealed enhanced neuronal activity in concurrence with increased glutamate and tissue acidosis up to seven days after occlusion. At 21-28 days after occlusion, neuronal activity decreased below baseline, while the acidotic but not the hyperglutamatergic state persisted. Notably, pharmacological blockade of the N-methyl-D-aspartate-type glutamate receptor, initiated at an early stage of CCH, suppressed the onset of neuronal hyperexcitation and subsequent deficits in neuronal activity. Altogether, we provide experimental evidence that CCH induces a glutamate surge and results in neuronal hyperexcitation at an early phase, which thereafter gives rise to a non-lethal but progressive deterioration of neuronal functions.

Indexed as

Brain IschemiaCerebrovascular CirculationNeuronsAnimalsBrainGlutamic AcidMagnetic Resonance ImagingMaleMiceMice, Inbred C57BLReceptors, N-Methyl-D-AspartateGlutamic AcidReceptors, N-Methyl-D-AspartateChronic cerebral hypoperfusionflavoprotein autofluorescence imagingmemantineneuronal hyperexcitationtwo-photon calcium imaging

Identifiers

PMID40370304
PMCPMC12511680

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.